Gastric microbiome and gastric cancer

Cancer Journal (United States)

Volumn 20, Issue 3, 2014, Pages 211-216

  Brawner, Kyle M ^a,b   Morrow, Casey D ^c   Smith, Phillip D ^a,d  

^a University of Alabama at Birmingham   (United States)

^b Department of Microbiology ^*  (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Cancer; H. pylori; microbiota; stomach

Indexed keywords

ANTIBIOTIC AGENT; BETA CATENIN; DISHEVELLED PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FRIZZLED PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; OMEPRAZOLE; TRANSCRIPTION FACTOR CDX1; VACUOLATING TOXIN;

ACIDOBACTERIA; ACTINOBACTERIA; ALLERGIC DISEASE; ALTERNATIVE HYPOTHESIS; ATROPHIC GASTRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIAL SECRETION SYSTEM; BACTERIAL STRAIN; BACTEROIDETES; BARRETT ESOPHAGUS; CANCER RISK; CHILDHOOD; CHRONIC INFLAMMATION; CLOSTRIDIUM; COEVOLUTION; ECOLOGICAL NICHE; ENVIRONMENTAL FACTOR; EPITHELIUM HYPERPLASIA; ESOPHAGEAL ADENOCARCINOMA; EXPOSURE; FIRMICUTES; FUSOBACTERIA; GASTRITIS; GASTROESOPHAGEAL REFLUX; GENETIC VARIABILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HYGIENE HYPOTHESIS; IMMUNE RESPONSE; IMMUNOBIOLOGY; INTESTINE FLORA; LACTOBACILLUS; MICROBIAL COMMUNITY; MICROFLORA; NONHUMAN; PATHOGENICITY ISLAND; PRIORITY JOURNAL; PROTEOBACTERIA; REGULATORY T LYMPHOCYTE; REVIEW; SPIROCHETE; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MICROFLORA; STOMACH MUCOSA; ANIMAL; COMPLICATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; PHYSIOLOGY; RISK FACTOR; STOMACH TUMOR;

ANIMALS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICROBIOTA; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84901486194     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0000000000000043     Document Type: Review

References (59)

1. Polk DB, Peek RMJr. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 2010;10:403-414.
2. Herrera V, Parsonnet J. Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect. 2009;15:971-976.
3. Jc Atherton, Cao P, Peek J, R.M., et al.Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J Biol Chem. 1995;270:17771-17777.
4. Ziel KA, Campbell CC, Wilson GL, et al. Ref-1/Ape is critical for formation of the hypoxia-inducible transcriptional complex on the hypoxic response element of the rat pulmonary artery endothelial cell VEGF gene. FASEB J. 2004;18:986-988. (Pubitemid 39561500)
5. Harris PR, Smythies LE, Smith PD, et al. Role of childhood infection in the sequelae of H. pylori disease. Gut Microbes. 2013;4:1-13 Epub ahead of print.
6. El-Omar EM, Carrington M, ChowW-H, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402. (Pubitemid 30164342)
7. Lee WP, Tai DI, Lan KH, et al. The-251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res. 2005;11:6431-6441.
8. Correa P, FonthamET, Bravo JC, et al. Chemoprevention of gastric dysplasia: fandomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst. 2000;92:1881-1888. (Pubitemid 32036918)
9. Shikata K, Kiyohara Y, Kubo M, et al. A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer 2006;119:196-201.
10. Knight ZA, Tan K, Birsoy K, et al. Molecular profiling of activated neurons by phosphorylated ribosome capture. Cell 2012;151:1126-1137.
11. Atherton JC, BlaserMJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest. 2009;119:2475-2487.
12. Linz B, Balloux F, Moodley Y, et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature 2007;445: 915-918.
13. Falush D, Wirth T, Linz B, et al. Traces of human migrations in Helicobacter pylori populations. Science 2003;299:1582-1585. (Pubitemid 36297709)
14. de Sablet T, Piazuelo MB, Shaffer CL, et al. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut Microbes. 2011;60:1189-1195.
15. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009;7:887-894.
16. El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut. 1998;43:327-333. (Pubitemid 28414912)
17. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev. 2005;85:495-522. (Pubitemid 40404635)
18. Isomoto H, Nakazato M, Ueno H, et al. Low plasma ghrelin levels in patients with Helicobacter pylori-associated gastritis. Am J Med. 2004; 117:429-432. (Pubitemid 39369548)
19. Nwokolo CU, Freshwater DA, O'Hare P, et al. Plasma ghrelin following cure of Helicobacter pylori. Gut. 2003;52:637-640. (Pubitemid 36528862)
20. Richter T, List S, Muller DM, et al. Five-to 7-year-old children with Helicobacter pylori infection are smaller than Helicobacter-negative children: a cross-sectional population-based study of 3,315 children. J Pediatr Gastroenterol Nutr. 2001;33:472-475. (Pubitemid 33070103)
21. Azuma T, Suto H, Ito Y, et al. Gastric leptin and Helicobacter pylori infection. Gut. 2001;49:324-329. (Pubitemid 32802564)
22. Furuta T, Shirai N, Xiao F, et al. Effect of Helicobacter pylori infection and its eradication on nutrition. Aliment Pharmacol Ther. 2002;16: 799-806. (Pubitemid 34407529)
23. Chen Y, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med. 2007;167:821-827. (Pubitemid 46658341)
24. Lundgren A, Stromberg E, Sjoling A, et al. Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients. Infect Immun. 2005;73:523-531. (Pubitemid 40041147)
25. Harris PR, Wright SW, Serrano C, et al. Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 2008;134:491-499. (Pubitemid 351173044)
26. Serrano C, Wright SW, Bimczok D, et al. Downregulated Th17 responses are associated with reduced gastritis in Helicobacter pylori-infected children. Mucosal Immunology. 2013;b:950-959.
27. Rhead JL, Letley DP, Mohammadi M, et al. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007;133:926-936. (Pubitemid 47374139)
28. Cover TL, Krishna US, Israel DA, et al. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res. 2003;63:951-957. (Pubitemid 36278424)
29. Gebert B, Fischer W, Weiss E, et al. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003;301: 1099-1102. (Pubitemid 37022312)
30. Oertli M, Sundquist M, Hitzler I, et al. DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest. 2012;122:1082-1096.
31. Kao JY, Zhang M, Miller MJ, et al. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 2010;138:1046-1054.
32. Gerhard M, Lehn N, Neumayer N, et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA. 1999;96:12778-12783. (Pubitemid 29513579)
33. Miehlke S, Kirsch C, Agha-Amiri K, et al. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer 2000;87:322-327. (Pubitemid 30451641)
34. Murata-Kamiya N. Pathophysiological functions of the CagA oncoprotein during infection by Helicobacter pylori. Microbes Infect. 2011;13: 799-807.
35. Ohnishi N, Yuasa H, Tanaka S, et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA. 2008;105:1003-1008. (Pubitemid 351282071)
36. Kaparakis M, Turnbull L, Carneiro L, et al. Bacterial membrane vesicles deliver peptidoglycan toNOD1 in epithelial cells. Cell Microbiol. 2010;12: 372-385.
37. Tsukashita S, Kushima R, Bamba M, et al. Beta-catenin expression in intramucosal neoplastic lesions of the stomach. Comparative analysis of adenoma/dysplasia, adenocarcinoma and signet-ring cell carcinoma. Oncology. 2003;64:251-258. (Pubitemid 36438810)
38. Murata-Kamiya N, Kurashima Y, Teishikata Y, et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene. 2007;26:4617-4626. (Pubitemid 47067401)
39. Suzuki M, Mimuro H, Kiga K, et al. Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe. 2009;5:23-34.
40. Nakayama M, Hisatsune J, Yamasaki E, et al. Helicobacter pylori VacAinduced inhibition of GSK3 through the PI3K/Akt signaling pathway. J Biol Chem. 2009;284:1612-1619.
41. Franco AT, Johnston E, Krishna U, et al. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res. 2008;68: 379-387. (Pubitemid 351380064)
42. Keates S, Sougioultzis S, Keates AC, et al. cag+ Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells. J Biol Chem. 2001;276:48127-48134.
43. Nagy TA, Frey MR, Yan F, et al. Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. J Infect Dis. 2009;199:641-651.
44. Maeda S, Yoshida H, Mitsuno Y, et al. Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori. Gut. 2002;50:771-778. (Pubitemid 34539037)
45. Bik EM, Eckburg PB, Gill SR, et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad SciUS A. 2006; 103:732-737. (Pubitemid 43153094)
46. Aebischer T, Fischer A, Walduck A, et al. Vaccination prevents Helicobacter pylori-induced alterations of the gastric flora in mice. FEMS Immunol Med Microbiol. 2006;46:221-229.
47. Lofgren JL, Whary MT, Ge Z, et al. Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. Gastroenterology 2011;140:210-220.
48. Devesa SS, Blot WJ, Fraumeni JF, Jr. Changing patterns in the incidence of esophageal and gastric carcincoma in the United States. Cancer 1998;83:2049-2053. (Pubitemid 28525384)
49. Tan MP, Kaparakis M, Galic M, et al. Chronic Helicobacter pylori infection does not significantly alter the microbiota of the murine stomach. Appl Environ Microbiol. 2007;73:1010-1013. (Pubitemid 46233523)
50. Rolig AS, Cech C, Ahler E, et al. The degree of Helicobacter pylori-triggered inflammation is manipulated by preinfection host microbiota. Infect Immun. 2013;81:1382-1389.
51. Atarashi K, Tanoue T, Oshima K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013;500:232-236.
52. Maldonado-Contreras A, Goldfarb KC, Godoy-Vitorino F, et al. Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J. 2011;5:574-579.
53. Kato S, Fujimura S, Kimura K, et al. Non-Helicobacter bacterial flora rarely develops in the gastric mucosal layer of children. Dig Dis Sci. 2006;51:641-646.
54. Levine SM, Lin EA, Emara W, et al. Plastic cells and populations: DNA substrate characteristics in Helicobacter pylori transformation define a flexible but conservative system for genomic variation. FASEB J. 2007; 21:3458-3467. (Pubitemid 350075136)
55. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004;291:187-194. (Pubitemid 38082812)
56. Lee CW, Rickman B, Rogers AB, et al. Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res. 2008;68:3540-3548.
57. Mowat C, Williams C, Gillen D, et al. Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology 2000;119:339-347. (Pubitemid 30621984)
58. Lertpiriyapong K, Whary MT, Muthupalani S, et al. Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis. Gut. 2014;63: 54-63.
59. Dicksved J, Lindberg M, Rosenquist M, et al. Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol. 2009;58:509-516.